These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25590278)

  • 1. Increased circulating levels of vitamin D binding protein in MS patients.
    Rinaldi AO; Sanseverino I; Purificato C; Cortese A; Mechelli R; Francisci S; Salvetti M; Millefiorini E; Gessani S; Gauzzi MC
    Toxins (Basel); 2015 Jan; 7(1):129-37. PubMed ID: 25590278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis.
    Smolders J; Peelen E; Thewissen M; Menheere P; Damoiseaux J; Hupperts R
    Mult Scler; 2014 Apr; 20(4):433-7. PubMed ID: 23959712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D, vitamin D binding protein, vitamin D receptor levels and cardiac dysautonomia in patients with multiple sclerosis: a cross-sectional study.
    Aktürk T; Turan Y; Tanik N; Karadağ ME; Sacmaci H; Inan LE
    Arq Neuropsiquiatr; 2019 Dec; 77(12):848-854. PubMed ID: 31939581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-β.
    Bălaşa R; Bajko Z; Huţanu A
    Mult Scler; 2013 Jun; 19(7):885-90. PubMed ID: 23207971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effect of IFN-beta 1a therapy on CCL2 (MCP-1) chemokine in patients with multiple sclerosis.
    Szczuciński A; Losy J
    Folia Neuropathol; 2004; 42(1):15-8. PubMed ID: 15119740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D in MS: a vitamin for 4 seasons.
    Ascherio A; Marrie RA
    Neurology; 2012 Jul; 79(3):208-10. PubMed ID: 22700805
    [No Abstract]   [Full Text] [Related]  

  • 7. Vitamin D status and effect of interferon-β1a treatment on MRI activity and serum inflammation markers in relapsing-remitting multiple sclerosis.
    Røsjø E; Myhr KM; Løken-Amsrud KI; Bakke SJ; Beiske AG; Bjerve KS; Hovdal H; Lilleås F; Midgard R; Pedersen T; Šaltytė Benth J; Torkildsen Ø; Wergeland S; Michelsen AE; Aukrust P; Ueland T; Holmøy T
    J Neuroimmunol; 2015 Mar; 280():21-8. PubMed ID: 25773151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.
    Smolders J; Hupperts R; Barkhof F; Grimaldi LM; Holmoy T; Killestein J; Rieckmann P; Schluep M; Vieth R; Hostalek U; Ghazi-Visser L; Beelke M;
    J Neurol Sci; 2011 Dec; 311(1-2):44-9. PubMed ID: 21620416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Albumin and Protein Oxidation are Predictors that Differentiate Relapsing-Remitting from Progressive Clinical Forms of Multiple Sclerosis.
    Oliveira SR; Kallaur AP; Reiche EMV; Kaimen-Maciel DR; Panis C; Lozovoy MAB; Morimoto HK; Maes M; Dichi I; Simão ANC
    Mol Neurobiol; 2017 May; 54(4):2961-2968. PubMed ID: 27026183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
    Thouvenot E; Orsini M; Daures JP; Camu W
    Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum protein binding of 1,25-dihydroxyvitamin D: a reevaluation by direct measurement of free metabolite levels.
    Bikle DD; Siiteri PK; Ryzen E; Haddad JG
    J Clin Endocrinol Metab; 1985 Nov; 61(5):969-75. PubMed ID: 3840175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
    Lutterotti A; Kuenz B; Gredler V; Khalil M; Ehling R; Gneiss C; Egg R; Deisenhammer F; Berger T; Reindl M
    J Neuroimmunol; 2006 Dec; 181(1-2):145-9. PubMed ID: 17046070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production.
    Hedegaard CJ; Sellebjerg F; Krakauer M; Hesse D; Bendtzen K; Nielsen CH
    Mult Scler; 2011 May; 17(5):567-77. PubMed ID: 21177756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypovitaminosis D association with disease activity in relapsing remitting multiple sclerosis in Brazil.
    Becker J; Callegaro D; Lana-Peixoto MA; Talim N; Vidaletti T; de Paula Corrêa M; Gomes I
    J Neurol Sci; 2016 Apr; 363():236-9. PubMed ID: 27000256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma ubiquitin-proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b.
    Minagar A; Ma W; Zhang X; Wang X; Zhang K; Alexander JS; Gonzalez-Toledo E; Albitar M
    Neurol Res; 2012 Jul; 34(6):611-8. PubMed ID: 22709658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon beta therapy increases serum ferritin levels in patients with relapsing-remitting multiple sclerosis.
    Sena A; Pedrosa R; Ferret-Sena V; Cascais MJ; Roque R; Araújo C; Couderc R
    Mult Scler; 2008 Jul; 14(6):857-9. PubMed ID: 18573825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of vitamin D-binding protein levels in the plasma of patients with generalized aggressive periodontitis.
    Zhang X; Meng H; Sun X; Xu L; Zhang L; Shi D; Feng X; Lu R; Chen Z
    J Periodontal Res; 2013 Feb; 48(1):74-9. PubMed ID: 22803589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon beta-induced restoration of regulatory T-cell function in multiple sclerosis is prompted by an increase in newly generated naive regulatory T cells.
    Korporal M; Haas J; Balint B; Fritzsching B; Schwarz A; Moeller S; Fritz B; Suri-Payer E; Wildemann B
    Arch Neurol; 2008 Nov; 65(11):1434-9. PubMed ID: 19001161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D-Binding Protein in Health and Chronic Kidney Disease.
    Denburg MR; Bhan I
    Semin Dial; 2015; 28(6):636-44. PubMed ID: 26332676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune regulatory effects of high dose vitamin D
    Muris AH; Smolders J; Rolf L; Thewissen M; Hupperts R; Damoiseaux J;
    J Neuroimmunol; 2016 Nov; 300():47-56. PubMed ID: 27806875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.